Ecolab Inc. vs Lemonade Inc — how do they compare? Ecolab Inc. trades at $281.36 (market cap $78.97B), while Lemonade Inc trades at $47.02 (market cap $3.63B). The key difference: Ecolab Inc. is far larger — about 21.8× Lemonade Inc's market cap, and Ecolab Inc. pays a 1.04% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecolab Inc. for 90 Days and Lemonade Inc for 27 Days on average.
| ECL | LMND | |
|---|---|---|
Market Cap | $78.97B | $3.63B |
Volume | 974,947 | 1,544,794 |
Sector | Basic Materials | Financials |
52-Week High | $308.35 | $96.57 |
52-Week Low | $245.73 | $43.91 |
Typical Hold Time | 90 Days | 27 Days |
Enterprise Value | $87.75B | $3.49B |
Dividend Yield | 1.04% | — |
Signals from Pluang's Aura AI — not financial advice
ECL trades at $278.10, down 0.97% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported $16.08B in 2025 revenue, with a net income margin of 12.57% and strong profitability metrics. Recent news highlights its dividend aristocrat status and growth in high-tech segments, while institutional buying and insider purchases reflect confidence.
Outlook remains positive with a consensus price target of $326.38, implying 17% upside, supported by analyst buy ratings (78%). Risks include elevated valuation multiples and increased debt from the CoolIT acquisition. Earnings growth in high-tech and digital segments is a key catalyst, though cost fluctuations pose headwinds.
Lemonade (LMND) trades at $46.83, up 1.14% with a bearish technical outlook despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Analyst sentiment is evenly split between buy/hold/sell with a $67 consensus target, while institutional activity shows mixed positioning. Recent expansion into Alaska and Kentucky renters insurance and pet insurance markets supports growth trajectory.
Lemonade's path to profitability remains the key investment thesis, targeting EBITDA positivity by late 2026. The stock offers growth potential through AI-driven efficiency and market expansion but carries significant execution risk amid persistent losses. Current valuation at 3.63x sales appears reasonable for the growth profile, though technical weakness near support at $45 requires monitoring.
Trailing returns across standard periods
Latest headlines on both assets
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →